top of page

With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs

  • msevcik1
  • Jan 13, 2023
  • 1 min read

WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s authority to crack down on unfair business practices — and the shift could have major implications for its ongoing scrutiny of pharmacy benefit managers.


 
 
bottom of page